Johnson and Johnson

OpenCalais Metadata: Ticker

JNJ

OpenCalais Metadata: LegalName

JOHNSON & JOHNSON

BioNTech is Already Working on Vaccine for the Covid Variant Omicron

BioNTech has begun work on a vaccine specifically for the new variant of the coronavirus Omicron, which was first identified in South Africa.

The development of an adapted vaccine is part of the standard procedure.

The first steps for a possible new vaccine are carried out in parallel with the assessment of whether one will be needed after the advent of Omicron.

Bulgaria Has Nearly 7 Million Doses of Vaccines

Many people lined up in front of vaccination points in the country in order to obtain a certificate that allows them to continue working.

"We have so far delivered nearly 7 million doses of vaccines, and 2.7 million doses have been injected," Bogdan Kirilov, the executive director of the Medicines Agency, told BNR.

Around Easter We Could See Peak of New Cases Claims Bulgarian Professor

"There will be a peak of infections around Easter. There is a bit of a false decrease. Antibodies created by vaccines manage to neutralize, albeit to different degrees, virologist Prof. Radka Argirova told BNT.

We have one and the same strain for a year and four months in Bulgaria. Vaccines had to be changed twice a year, she added.

Vučić reveales when vaccination starts and what vaccines will be at our disposal

When the vaccination will start, whether at the beginning of next year, depends on the experts and their assessments, Vui said and added that it could happen in January.
"We will have two vaccines, and I hope three," said Vucic, adding that it would show that Serbia is among the countries that behaved best during the epidemic.

Pages